Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
About this item
Full title
Author / Creator
Publisher
England: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
England: Oxford University Press
Subjects
More information
Scope and Contents
Contents
A better understanding of cancer biology has led to the development of molecular targeted therapy, which has dramatically improved the outcome of some cancer patients, especially when a biomarker of efficacy has been used for patients' selection. In head and neck oncology, cetuximab that targets epidermal growth factor receptor is the only targeted...
Alternative Titles
Full title
Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7049986
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7049986
Other Identifiers
ISSN
2515-5091
E-ISSN
2515-5091
DOI
10.1093/jncics/pkz055
